Thursday, July 23, 2020

Human Insulin Market by Key Types, Detail Analysis and Forecasts To 2023

Human Insulin Market Research Report: Information by Type Traditional Human Insulin and Modern Human Insulin, by Indication Type 1 Diabetes and Type 2 Diabetes, and by End-User Hospitals and Clinics and Research Institutes- Global Forecast Till 2023
Human Vaccines Market - Scenario
Human insulin is synthetic insulin manufactured in laboratories by growing the insulin protein with the help of E. coli bacteria. The Global Human Insulin Market is driven by the increasing prevalence and occurrence of Diabetes Mellitus (DM) and the increasing demand for human insulin. Additionally, the increasing technological innovations and the rising awareness and screening for diabetes mellitus also drive the market.
Growing emphasis on diabetes management including new treatment options and rising geriatric population are various other factors that accelerate the growth of the market.
Human Insulin Market - Scenario
Human insulin is synthetic insulin manufactured in laboratories by growing the insulin protein with the help of E. coli bacteria. The global human insulin market is driven by the increasing prevalence and occurrence of Diabetes Mellitus (DM) and the increasing demand for human insulin.
Additionally, the increasing technological innovations and the rising awareness and screening for diabetes mellitus also drive the market. Growing emphasis on diabetes management including new treatment options and rising geriatric population are various other factors that accelerate the growth of the market.
The global Human Insulin Market is expecting a healthy growth at a CAGR of 12.1% during forecast period.
Human Insulin Market - Key players
Some of the major players in the global human insulin market are Biocon Ltd, Tonghua Dongbao Pharmaceuticals Co., Ltd., ADOCIA, Merck & Co, Julphar, Pfizer, Inc, Bristol-Myers Squibb Company, GlaxoSmithKline, Oramed Pharmaceuticals, Inc, Novo Nordisk A/S, and Sanofi.
Human Insulin Market - Segmentation
The global human insulin market is segmented by type, indication, and end-users.
On the basis of type, it is segmented into accessories and devices.
On the basis of methods, it is segmented into traditional human insulin and modern human insulin.
On the basis of applications, it is segmented into type 1 diabetes and type 2 diabetes.
On the basis of end-users, it is segmented hospitals, forensic laboratories, research centers, and others.
Human Insulin Market - Intended Audience
Research and Development (R&D) Companies
Insulin & Genomic Industries                                      
Medical Research Laboratories         
Academic Medical Institutes and Universities
Human Insulin Market - Regional analysis
America is the largest market for human insulin. The growth of the market is driven by the inclination towards quality healthcare, increase in healthcare spending, and the presence of leading players. The U.S. is the largest market followed by Canada. South America is expected to be the fastest growing regions.
The European market for human insulin is driven by research funding in diabetes diagnosis and treatment and presence of huge population suffering from diabetes. In Germany, the market is driven by the increasing government support for research and development activities and a huge demand for human insulin. The increasing prevalence of obesity and unhealthy lifestyle of the people further increase the risk of diabetes among the European population.
In Asia Pacific, the human insulin market is fueled by the rising awareness of human insulin and a huge population base. China, Japan, and India are the major contributors to the growth of the market due to improvement in disease diagnosis and treatment services and development of the healthcare infrastructure. Furthermore, the presence of huge geriatric population diagnosed with diabetes also fuels the growth of the market in countries such as India and China in Asia Pacific. 
In the Middle East & Africa, the market exhibits the growth owing to the rising demand for treatment services and need for primary care services. In countries such as United Arab Emirates (U.A.E.), Saudi Arabia, and Oman the availability of specialty care services and changing lifestyles of the people are the major drivers for the growth of the market. In Africa, poor economic condition and less development in medical facilities also determine the demand for diagnosis and treatment services.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Extracorporeal Membrane Oxygenation Machine Market Forecasts by Global Industry Till 2023

Extracorporeal membrane oxygenation machine market has been registering increasing revenue as a result of several factors that include increasing use of ECMO machine for open heart surgeries or procedures that involve life threatening cardiovascular and respiratory diseases. Expanding geriatric population, rising prevalence of lung diseases, improvement in ECMO technology are expected to be other driving forces for the ECMO machine market over 2019-2025.
ECMO Highlights/ Market Information:
Increasing number of hospitals and other medical facilities have been reported to have ECMO machines. For instance, in a 2017 report published by the World Health Organization, around 306 hospitals in the U.S. used ECMO machines for the treatment of lung and heart diseases. Additionally, there were 9385 instances of ECMO administration in U.S. hospitals in 2017. Extracorporeal Membrane Oxygenation Machine Market is anticipated to record a CAGR of 4.8% over 2019-2025 and amass an estimated revenue of USD 267.60 million by 2025.
ECMO machines are also known as life support machines. They are designed to oxygenate blood outside the patient’s body and allows the heart and lungs to rest. The ECMO machine works by taking the blood out of the body, into an artificial lung where it adds oxygen and removes carbon dioxide. The blood is then armed to body temperature and pumped back into the body.
Some of the factors such as chances of bleeding, stroke, infection and kidney failure may hamper the growth of ECMO machine market. However, in spite of risks, ECMO machines have been known to save lives and are an integral part of heart and lung bypass surgeries which will continue to add to ECMO machine market revenue by 2025.
Key Players:
Owing to the lifesaving qualities of ECMO machines, they are being increasingly incorporated into hospitals and other medical institutions which has urged ECMO machine market players to invest more into R&D that support the technological growth of ECMO machines. As a result, ECMO machine market has become a competitive space where some of the giants of healthcare device manufacturers are vying with each other to capture a greater market share. Some of these companies include, Medtronic, Siemens, Abbott, Getinge Group, Agilent technologies, Livanova PLC, Terumo Corporation, Nipro Corporation, Fresenius Medical Care AG & Co, ALung technologies etc.
Industry News:
To cite an instance of the growing interest that the ECMO machine market is witnessing it can be mentioned that ALung Technologies, a compny that is considered to be one of the leaders in the low-flow extracorporeal carbon dioxide removal technology, closed a $36 million Series C funding round in 2017. According to plans reported by ALung Technologies, the fund was meant to support the trial for FDA approval of the Hemolung Respiratory Assist System (RAS) developed by the company that was essentially a minimally invasive artificial lung device designed to remove carbon dioxide independently of the lungs through a process called Respiratory Dialysis.
Segmentation Analysis/Regional Analysis:
ECMO machine market divides the market on the basis of component, modality, application and region.
ECMO machine consists of different components such as pumps, controllers, oxygenators, cannula and accessories. ECMO machine market has registered revenue growth on as each component segment has showed growth prospects as ECMO machines have come to be more widely used. Oxygenators segment is expected to record considerable CAGR over 2019-2025 and hold a major ECMO machine market share due to increased application ECMO machines in treatment of heart and lung diseases.
On the basis of modality, ECMO machine market is further segmented as veno-arterial, arteries-venous and veno-venous. Due to the expansive use of veno-arterial ECMO machines in case of cardiac collapse, veno-arterial modal segment of ECMO machine market is expected to hold a major market share while increasing cases of cardiac shock is expected to help in the fast growth of veno-venous modal segment in the coming years.
ECMO machine market has several application segmentations which include respiratory, cardiac and extracorporeal cardiopulmonary resuscitation. Due to the crucial role that ECMO machines play in case of pulmonary function support, respiratory application is anticipated to witness substantial growth in the coming years. On the other hand, increasing incidence of cardiac illnesses is expected to fuel the growth of extracorporeal cardiopulmonary resuscitation or ECPR segment.
On the basis of region ECMO machine market is subdivided into Americas, Europe, Asia Pacific and MEA.
Browse Complete 95 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Hemoglobinopathies Market Key Factors Analysis, Worldwide Trend and Growing Business Demand Till 2023

Hemoglobinopathies Market Research Report: Information by Type (Thalassemia (Alpha Thalassemia, Beta Thalassemia), Sickle Cell Disease and other Hb Variant Diseases), Treatment (Stem-cell Transplantation, Blood Transfusions, Analgesics, Antibiotics, ACE inhibitors, Hydroxyurea), End User (Hospitals & Clinics, Diagnostics Laboratories and others)
Hemoglobinopathies Market Highlights:
Hemoglobinopathies are also known as hemoglobinopathy. It is the medical term referred to the group of blood disorders and diseases that affect red blood cells. Hemoglobinopathies are inherited single-gene disorders, and in most cases, it is inherited as autosomal co-dominant traits.
The Hemoglobinopathies Market is estimated to drive the market growth owing to the rising prevalence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E. Also, a low level of hygiene and poor healthcare infrastructure are some key factors attributing to the growth of the target population in low-income regions such as South-East Asia, the Mediterranean basin, and Africa. However, the lack of treatment and diagnosis awareness may hamper market growth over the forecast period.
Hemoglobinopathies Market Key Players
Some of the key players in the global hemoglobinopathies market are Sanofi, Sangamo Therapeutics Inc., Global Blood Therapeutics, Bluebird Bio Inc., Emmaus Life Sciences Inc., Prolong Pharmaceuticals, Celgene Corporation, Alnylam Pharmaceuticals, Gamida Cell, Acceleron Pharma, Mast Therapeutic, HemaQuest Pharmaceuticals, and Invenux.
Hemoglobinopathies Market Segmentation
The global hemoglobinopathies market is segmented based on type, treatment, test types, and region.
The global market for hemoglobinopathies, by type, is segmented into thalassemia, sickle cell disease, and other Hb variants diseases. The thalassemia segment is further classified as alpha thalassemia and beta thalassemia. The sickle cell disease segment is expected to hold the largest market share of the hemoglobinopathies market owing to the presence of strong product pipelines such as LentiGlobin and rising prevalence of sickle cell disease.
Based on treatment, the market is classified into stem-cell transplantation, blood transfusions, analgesics, antibiotics, ACE inhibitors, and hydroxyurea. Also, based on treatment, the blood transfusion segment holds the largest market share owing to significant success rate and increasing adoption of this treatment option.
The market by end user, has been segmented into hospitals & clinics, diagnostics laboratories, and others.
On the basis of region, the global hemoglobinopathies market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Hemoglobinopathies Market Regional Analysis
The global hemoglobinopathies market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hemoglobinopathies market in the Americas has further been segmented into North America and South America, with the North America market further classified into the US and Canada.
The European hemoglobinopathies market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The hemoglobinopathies market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The hemoglobinopathies market in the Middle East & Africa has been segmented into the Middle East and Africa.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables And Figures At https://www.marketresearchfuture.com/reports/hemoglobinopathies-market-8098
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Dental Forceps Market World Legend Industry Overview, Analysis and Forecast 2020 to 2023

Market Research Future (MRFR) Announces the Publication of its Research Report Global Dental Forceps Market, 2019–2023. The Global Dental Forceps Market is Expected to Register a CAGR of ~ 5.2% During the Forecast Period, with a Market Value of USD 451.58 Million.
Dental Forceps Market Overview:
The increasing demand for Dental Forceps Market for performing various types of dental surgical procedures and the rising number of dental practitioners & dental clinics is expected to boost the growth of the market. As per the data published by the American Dental Association (ADA), about 199,486 dentists were working in dentistry in the US in 2018. Moreover, the increasing incidence of dental diseases and the growing demand for cosmetic dentistry is anticipated to boost the growth of the market during the assessment period. According to the data published by the National Health Services (NHS), about 22.1 million adults were seen by an NHS dentist in the between July 2016-July 2018.
On the other hand, factors such as the availability of advanced dental equipment and limited reimbursement for dental surgeries that may hamper the market growth during the forecast period.
Key Players:
Some of the key players in the global dental forceps market are Otto Leibinger GmbH, Karl Schumacher, iM3, Erbrich Instrumente, Carl Martin GmbH, Hu-Friedy, Kruuse, Helmut Zepf Medizintechnik GmbH, ASA DENTAL S.p.A., and J&J Instruments.
Segmentation:
The global dental forceps market has been segmented into product type and end user.
The market, based on product type, has been segmented into Maxillary forceps, Mandibular forceps, Pediatric forceps, Adult forceps, Anterior forceps, and others. The adult segment is anticipated to hold the largest market share owing to the growing prevalence of dental problems in adults. The pediatric segment is expected to be the fastest-growing due to the increased cases of dental caries among the children.
The market, by end user, has been segmented into dental hospitals, dental clinics, and others. Dental clinics segment is expected to hold the major share as a majority of people visit dental clinics for treatment.
The market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The dental forceps market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European dental forceps market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The dental forceps market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The dental forceps market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Analysis
Geographically, Americas is anticipated to hold major market position owing to various factors such as the rise in geriatric population, increasing government expenditure on oral healthcare across, and rising adoption of dental cosmetic treatments in the region. According to the data published by the American Dental Association (ADA), the national dental care expenditures were about USD 117.5 billion in 2015.
Europe is anticipated to show a significant amount of growth in the global dental forceps market. The increasing number for dental procedures, rising prevalence of dental disorders, growing disposable income, and rise in dental tourism are some factors that are anticipated to support the market growth in the region. According to the data published by the Public Health England, in 2015-16, about Euro 50.5 million were spent on tooth extractions in the population under the age of 19 years.
The Asia-Pacific region is expected to be the fastest growing market for dental forceps. The market growth is attributed to the rising prevalence of dental problems, growing disposable income, and an increasing number of dental surgeries in the region.
The dental forceps market in the Middle East & Africa is expected to account for the lowest share of the global market due to low disposable incomes and limited awareness about oral health, especially in the African region.
Browse Complete 160 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/dental-forceps-market-8012
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Breast Feeding Accessories Market Advanced Technologies, Industry Size, Iconic Revenue, Shares, Trends and Demand by 2023

Breast Feeding Accessories Market Research Report: Information by Product (Breast Pumps, Breast Milk Bottles, Nipple Care Products, Breast Shells, Breast feeding Pillow and Cleaning Products), End User (Hospitals & Clinics and Personal) and Region - Global Forecast till 2024
Segmentation:
The global Breast Feeding Accessories Market Growth is segmented on the basis of product and end user. On the basis of the product, the global Breast-feeding accessories market is categorized into breast milk bottles breast pumps, nursing clothes, Breast feeding pillow, nursing pads, nipple care products, cleaning products, breast shells and other accessories. On the basis of the breast pump, the products are sub-segmented into manual breast pumps and electric breast pumps. The nursing pads are further sub-segmented into disposables and reusable.  On the basis of the end user, the market is segmented into hospital & clinics and personal.
On the bases of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is expected to hold the largest market share and the Middle East and Africa with a low market share during the forecasted period.
Key Players:
Koninklijke Philips N.V. (UK), Medela LLC (US), Ameda (US), Pigeon Corporation (Japan), Nuby (USA), Artsana S.p.A. (UK), Handi-Craft Company (US), Medline Industries, Inc.(US), NNUK USA LLC (US), Tommee Tippee/Mayborn Group Limited  (UK) and Others are some of the major players for global Breast feeding accessories market.
Breast Feeding Accessories Market Highlights:
Breast feeding plays a very important role in the growth and development of new-born babies. Maternal Breast feeding is a biological process, but, in some cases, women require some aids to feed their babies effectively. There is a high demand of Breast-feeding accessories in hospitals, clinics, and personal use.
Breastfeeding plays a very important role in the growth and development of new-born babies. Maternal breastfeeding is a biological process, but, in some cases, such as difficulty in breastfeeding due to irregular milk flow is creating the demand for breastfeeding accessories to feed their babies effectively.
The major key factors driving the market growth are difficulty in milk secretion or lactation in the mothers, increasing rate of adopting new babies, and an increase in the number of working mothers.  Also, the growing awareness about the breastfeeding accessories, decreasing infant mortality rate, improving healthcare infrastructure in emerging economies, and favorable policies promoting breastfeeding in North America, Europe, and various regions promotes the market growth. However, the problem associated with breast feeding accessories and high cost of the products hamper the market growth.
Regional Analysis:
The Americas dominate the global breast feeding accessories market due to the rise in woman employment, increasing healthcare infrastructure, and conducting breastfeeding programs by healthcare companies in this region drives the market growth within America. For instance, Medela LLC launched a new rental program for the breast pumps used in hospitals to help breastfeed successfully.
Europe is estimated to hold the second position in the global breast feeding accessories market owing to increasing government support for the healthcare sector, and the rising awareness programs about the breast feeding conducted by different foundation contributors is promoting the market across the globe.
 The Asia-Pacific region is the fastest growing market owing to the increasing birth rate, huge woman employment rate, and increasing healthcare expenditure drives the market with the region. The Middle East & Africa has the least share in the global breast feeding accessories market owing to the presence of poor economies and low per capita income, especially in the African region.
Browse Complete 110 Pages Premium Research Report Enabled with 60+ Tables and Figures at https://www.marketresearchfuture.com/reports/breast-feeding-accessories-market-8010
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Clinical Trials Market Forecasts by Global Industry Revenue and Demand Analysis in 2020 MRFR Report

Clinical Trials are Medical Investigations to Use for Research and Testing Purposes for the Evaluation of the Accuracy, Efficiency, and Effects of New Medical Treatments on Human health.
Global Clinical Trials Market Highlights:
According to a detailed report published by Market Research Future (MRFR), the Global Clinical Trial Market has been assessed to grow exponentially at a CAGR of 5.7% over the forecast period.
The global Clinical Trials Market is expected to grow owing to influential factors such as the rising demand for clinical trials due to the global expansion of the healthcare sectors, increasing expenditure towards research and development of the pharmaceutical industry, growing prevalence of chronic diseases, and the focus on the treatment methods for rare diseases.
Segmental Analysis:
The global clinical trials market has been segmented based on phase, study design, indication, end users, and region.
Based on the phase, the market has been segmented into phase I, phase II, phase III, and phase IV. Among these, the phase III trial segment has been assessed to lead the market as the largest segment, owing to its high val0ue in the healthcare sector, as well as its comparatively superior effectiveness. Phase I trial segment has been expected to grow at the fastest growth rate during the forecast period, owing to the increase in its applications in investigative new drug (IND) sector, technological advancements, and the rising government initiatives to improve the healthcare sector in emerging economies.
Based on the study design, the global clinical trials market has been segmented into expanded access interventional, and observational.
Based on indication, the global clinical trials market has been segmented into autoimmune/inflammation, cardiovascular, central nervous system (CNS) condition, diabetes, obesity, oncology, pain management, and others.
Based on the end-user, the clinical trials market is segmented into dental hospitals & clinics, dental institutes, and dental academic and research institutes.
Based on the region, the global clinical trials market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
Key Players:
The key players identified in the global clinical market are Charles River Laboratories, Clinipace, Eli Lilly and Company, ICON plc, Laboratory Corporation of America, Novo Nordisk A/S, Paraxel International Corporation, Pfizer, Quintiles IMS, SGS SA, among others.
Regional Analysis:
The Americas have been assessed to dominate the global clinical trials market owing to the presence of multiple major pharmaceutical companies, rise in the patient population, and the increasing innovations towards product development. Additionally, the growing cases of patients suffering from chronic diseases such as cancer, diabetes, and other life-threatening diseases increases the demand for innovative drugs and contributes to the improvement of clinical trial methods to expand treatment options. These factors are also estimated to drive the clinical trials market in the region over the forecast period.
Europe has been identified as the second leading regional market for clinical trials, owing to factors such as an increase in the expenditure towards research and development in the pharmaceutical industry, and growing prevalence of chronic diseases is predictable to give a further boost to the clinical trial market. Additionally, favorable government regulations for clinical trials further support the market growth in the region and increases the demand for new products across Europe, which will consequently lead to market growth over the forecast period.
The Asia Pacific region has been assessed as the fastest growing market  for clinical trials during the forecast period, owing to the increasing incidence of diseases, growing focus of the governments on developing medications for rare diseases and the growth in the export sector contributes substantially to the clinical trial market in the region. In countries like India, China, and Australia, the developing economy and low cost to operate clinical trial facilities supply the market growth in this region.
The Middle East & Africa has been estimated to witness slow, gradual growth in the global clinical trials market over the forecast period, owing to the presence of weak economies, lesser technical amenities, lack of medical knowledge, and limited clinical trials centers, especially in the African region decrease the market growth. The Middle East has been expected to contribute the majority of the market share in this region, due to the presence of a well-established healthcare sector and huge healthcare expenditure by the governments of countries like Saudi Arabia, Kuwait, and Qatar.
Browse Complete 110 Pages Premium Research Report Enabled With Respective Tables And Figures At https://www.marketresearchfuture.com/reports/clinical-trials-market-7787
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Aortic Aneurysm Market SWOT Analysis, Key Players, Analysis and Forecasts Till 2023

MarketResearchFuture.com Presents “Global Aortic Aneurysm Market 2020 by Manufacturers, Regions, Type and Application, forecast to 2023” Furthermore, this Research Report Categorizes the Market by Companies, Region, Type and End-use Industry.
Segmentation
The global aortic aneurysm market has been segmented into type, product, treatment, end user, and region.
By type, the market has been segmented into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA).
On the basis of product, the market has been divided into stent-grafts, catheters, and others.
By treatment, the market has been classified into endovascular aneurysm repair (EVAR) and open surgical repair (OSR).
Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.
Aortic Aneurysm Market Highlights:
The global aortic aneurysm market held a market value of USD 2,357.6 million in 2017 and is projected to grow at a CAGR of 8.4% over the forecast period. An aortic aneurysm is an abnormal enlargement or bulging of the wall of the aorta. Aortic Aneurysm Market has two types such as an abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). An abdominal aortic aneurysm is an aneurysm in the part of the aorta that passes through the abdomen while thoracic aortic aneurysm is an aortic aneurysm that presents mainly in the thorax.
Some of the market growth factors include rising prevalence of tobacco smoking in the developed and developing countries, worldwide growing elderly population coupled with the increasing burden of cardiovascular diseases, favorable reimbursement scenarios for surgical treatment of aortic aneurysms, and mounting technological advancements in products. In contrast, the presence of low reimbursement rates in the developing countries and higher cost of aortic aneurysm treatment and devices are anticipated to hinder the market growth during the next five years.
Key Players:
Some of the spearheading players in the global aortic aneurysm market are
  • Medtronic plc
  • Cook Medical
  • Terumo Medical Corporation
  • Microport Scientific Corporation
  • MAQUET Holding B.V. & Co. KG
  • Endologix Inc.
  • L. Gore & Associates
  • Lombard Medical Limited
  • JO0TEC AG (CryoLife Inc.)
  • and Cardinal Health Inc.
Regional Analysis
The global aortic aneurysm market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would continue its supremacy over the forecast period attributed to the presence of sophisticated medical and healthcare infrastructure and major market participants, higher spending on the healthcare, and frequent launches of novel devices in the US and Canada. For instance, in 2015, Cook Group Incorporated launched its Zenith Alpha abdominal endovascular graft in Canada.
Europe would be the second-largest value contributor in the aortic aneurysm market due to the highest prevalence of tobacco smoking and the presence of favorable initiatives by several organizations to reduce the burden of aortic aneurysm. For instance, the World Health Organization (WHO) stated that presently, Europe has the highest prevalence of tobacco smoking among adults (28%) and some of the highest prevalence of tobacco use by adolescents.
Asia-Pacific is likely to witness the fastest market growth during the forecast period due to growth in increasing geriatric population and prevalence of cardiovascular diseases & hypertension, and growing awareness about aortic aneurysm treatment, and developing healthcare infrastructure in India, China, and Australia. For instance, WHO reported that one million people in the World Health Organization Western Pacific Region die each year from cardiovascular disease caused by tobacco use and more than 1 in 5 cardiovascular diseases, such as heart attack and stroke, result from smoking?
The Middle East & Africa has the least share of the global aortic aneurysm market. In addition, the major market share of the region would be held by the Middle Eastern region. Several studies reported that aortic aneurysm is very rare in the Middle East and very few lives are threatened by deadly aortic aneurysms annually in the Middle East region.
Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/aortic-aneurysm-market-7776
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Wednesday, July 22, 2020

Fabry Disease Market Highlights | Industry Dynamics | Business Overview | Iconic Revenue and 2023 Insight

As Per the Latest Market Intelligence Report Published by Market Research Future, the Molecular Diagnostics Market is Progressively Growing in the Forecasted Period.
Key Players:
Some of the prominent players in the global Fabry disease market are Amgen Inc., Amicus Therapeutics, Inc., AVROBIO, Inc., Idorsia Pharmaceuticals Ltd, Protalix, Bristol-Myers Squibb Company, GlaxoSmithKline, iBio, Inc., Neuraltus Pharmaceuticals, Inc., Novartis AG, Pfizer Inc., Sanofi, Shire, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd and others.
Fabry Disease Market Highlights:
The Global Fabry Disease Market is expected to grow at a CAGR of 6.8% during the forecast period. Technological advancements, strong pipeline, advancements in healthcare facilities, and favorable funding policies are expected to drive the market growth over the forecast period. Owing to the increasing awareness about Fabry disease, new and existing market players are coming up with better treatment approaches. For instance, in 2018, 2018, Amicus Therapeutics launched Galafold capsules 123mg for the treatment of patients aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation.
However, diverse range of symptoms, and related complications can restrain the market growth over the assessment period.
Segmentation:
The Global Fabry Disease Treatment Market has been segmented into type, diagnosis & treatment and end user.
The market, on the basis of type, has been segmented into type-1 and type-2. The type-2 Fabry disease holds the major market share due to the high occurrence of type-2 Fabry disease i.e. 1 in 1,500 to 4000 males.
The market, by diagnosis & treatment, has been segmented into diagnosis and treatment. The diagnosis segment is further classified as blood test, urine test, thyroid test, lung function test, and imaging. The imaging segment includes electrocardiogram (EKG), echocardiogram, brain MRI, CT scan and others. The treatment segment is further classified as enzyme replacement therapy, gene therapy, pharmaceutical formulations containing agalsidase alfa, analgesics, anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), and others.
The market, by end user, has been segmented into hospitals & clinics, diagnostic centers, research & academic institutes, and others.
Regional Analysis:
Geographically, the Americas is expected to dominate the global market owing to the increasing technological advancements and rising research and development activities. Gastrointestinal manifestations such as abdominal pain, diarrhea and nausea are significant burden in a patient with Fabry disease. So, for the advanced treatment of these patients SmartPill testing procedure is developed to gain additional understanding of Fabry disease manifestation via motility abnormalities in order to improve symptom targeted therapy. This device is currently under clinical trial and the sponsor of this study is Massachusetts General Hospital.
Europe is expected to hold the second largest market share. Nearly 2.2 in 10,000 people in the European Union (EU) are affected with Fabry disease and Fabrazyme (agalsidase beta), Galafold (migalastat) and Replagal (agalsidase alfa) are the three authorized drugs used for the treatment of Fabry disease.
Asia-Pacific is expected to be the fastest growing market owing to the improving healthcare infrastructure.
Moreover, the Middle East and Africa region is expected to hold the least market share in the global Fabry disease market.
Browse Complete 50 Pages Premium Research Report Enabled with Respective Tables And Figures At https://www.marketresearchfuture.com/reports/fabry-disease-market-7064
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
at No comments:

Irritable Bowel Syndrome Treatment Market SWOT Analysis, Key Players, Analysis and Forecasts Till 2023

Looking at the Current Market Trends as well as the Promising Demand Status of the “Irritable Bowel Syndrome Treatment Market” it can be Projected that the Future Years Will Bring out Positive Outcomes – Avail Prime Report by MRFR
Irritable Bowel Syndrome (IBS) Treatment Market Overview:
The Global Irritable Bowel Syndrome (IBS) Treatment Market is showing impressive signs of attaining a CAGR of 7.58% between 2018 and 2023. The forecast period would also witness a touching of a valuation of USD 2900mn by the end of 2023. Irritable bowel syndrome is a disease that triggers immense pain in the stomach that, if not cured in time, could lead to depression. The problem can be a long-lasting one. Market Research Future (MRFR) report has found out that the market is evolving due to the growing awareness that is making people seek better treatment.
Several factors like better Irritable Bowel Syndrome Market awareness, high expenditure capacity, and increasing ingress of various technologies can impact the global market. Pharmaceutical industries are impacting the market with various innovation and others.
Competitive Landscape:
A lot of companies are making substantial movement by launching tactical changes. These companies are Allergan Inc., Valeant Pharmaceuticals international, Inc., Lexicon Pharmaceuticals, Inc., Astellas Pharma, Inc., Mallinckrodt, Synergy Pharmaceuticals Inc., Nestle Health Science, Ardelyx, Inc., Ironwood Pharmaceuticals, and Abbott. MRFR recorded the latest moves initiated by these companies to make sure that a chart can be drawn for the market in the future, which can be used to predict various movements in the coming days.
In September 2019, Ardelyx, a California-based cardiorenal specialist, won FDA’s approval for their latest medicine Ibsrela, which can be considered as an oral treatment for irritable bowel syndrome with constipation (IBS-C). The medicine is for adults. The approval finds nod from two clinical trials, T3MPO-1 and T3MPO-2, it also relied on a long-term result from T3MPO-3. The small molecule present in the medicine acts in the gastrointestinal (GI) tract to hinder NHE3 from gaining momentum, which ensures better bowel movements.
Segmentation:
The report on the global irritable bowel syndrome treatment market makes it extensive by segmenting the market into type, drug type, and end user. These segments carry various factorial details and trigger better understanding with volume-wise and value-wise understanding.
By type, the global market for irritable bowel syndrome treatment includes IBS-C, IBS-D, and IBS-M. IBS-D is has the potential to emerge as the major shareholder over the forecast period.
By drug type, the report on the global irritable bowel syndrome treatment market includes linaclotide, lubiprostone, rifaximin, eluxadoline, and alosetron. The Linaclotide segment has the potential to take over the market.
By end use, the report containing study of the global irritable bowel syndrome treatment market encompasses clinics, research laboratories, hospitals, and others. The Hospitals segment has the better market coverage.
Regional Analysis:
North America is expected to make better contribution for the irritable bowel syndrome market. The regional market has better market opportunities due to their high expenditure capacity. Better healthcare facilities, high investment for research & development sector, medicines lined up in the pipeline, and others are expected to make strong contributions for the regional market. In addition, the presence of top-notch pharmacies and countries like the US, Canada, and others are expected to earn more revenues for the market.
Europe is expected to portray similar growth patterns, which can trigger a high influx of revenues. The market is also known for the presence of several market players who are impacting it with their innovations. On the other hand, they are collaborating with various other players to make substantial impact on the market.
The APAC market has better opportunities as the global players are looking for constant incorporation of efforts from regional governments, which they are receiving. In addition, the region has become a perfect business expansion plans for these companies. Hike in expenditure capacity, better medical facilities, and others are expected to make the market contribute the most in the coming years. Its massive population can also play a crucial role by allowing easy permeation for the market.
Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/irritable-bowel-syndrome-treatment-market-7044
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
at No comments:

Hypothyroidism Market Segments, Key Players Strategies, Analysis and Forecasts Till 2023

“Hypothyroidism Market Research Report – Global Forecast till 2023” Report Present to MarketResearchFuture.com, Particularly Study on Hypothyroidism Segment and Sub Segments, Future Growth Analysis, Size and Share - Outlet Till 2023
Hypothyroidism Market - Overview
The Hypothyroidism Market is expected to grow at a CAGR of 3.7% during the forecast period. Increasing prevalence of hypothyroidism, advancements in healthcare facilities, and favorable reimbursement and funding policies are expected to drive the market growth over the forecast period. According to information suggested by the 2017 guideline of the American Thyroid Association (ATA), 20 million Americans had some form of hypothyroidism disorder. However, side-effects related to available therapeutics can restrain the market growth over the assessment period.
Hypothyroidism Market - Key Players   
Some of the prominent players in the global hypothyroidism market are Pfizer Inc., AbbVie Inc., Merck & Co., Inc., ALLERGAN, Mylan N.V., Erfa Canada Inc, Novartis AG, GlaxoSmithKline plc, RLC Labs and others
Hypothyroidism Market - Segmentation
The Hypothyroidism Treatment Market has been segmented into type of hypothyroidism, diagnosis & treatment, route of administration and end user.The market, on the basis of type of hypothyroidism, has been segmented into primary hypothyroidism, secondary hypothyroidism, and tertiary hypothyroidism.The Global market, on the basis of diagnosis & treatment, has been segmented into diagnosis and treatment. The diagnosis segment is further classified as physical examination, blood tests, imaging scan, and others. The treatment segment is further classified as levothyroxine sodium, liothyronine, and natural desiccated thyroid (NDT).
The levothyroxine sodium is expected to hold the largest market share owing to the growing prevalence of thyroid disorder, and effectiveness of drug. The Synthroid drug by Abbvie holds the major share in the US market. In 2016, Abbvie Inc. generated revenue of 763 USD million with Synthroid drug in US only.The Global Hypothyroidism Market, by route of administration, has been segmented into oral, intravenous, and others. The Global market, on the basis of end users, has been segmented into hospitals, clinics, research & academic institutes and others.
Hypothyroidism Market - Regional Analysis
Geographically, the Americas is expected to dominate the global market owing to the increased prevalence of hypothyroidism. According to the American Thyroid Association, more than 12% of the US population develops a thyroid disorder during their lifetime. Europe is expected to hold the second largest position in the global market owing to the favorable reimbursement and funding policies. According to the Thyroid UK in 2016/2017, the National Health Service (NHS), England spent more than ~USD 42 Million on liothyronine (a drug for the treatment of hypothyroidism). Asia-Pacific is expected to be the fastest growing market owing to the presence of a large patient pool and improving healthcare infrastructure. According to a study published in the Journal of Clinical and Diagnostic Research in 2016, nearly 42 Million people residing in the country suffer from thyroid disorders. This prevalence of thyroid, consequently, results in an increased demand for therapeutic. This is projected to drive market growth. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.
Browse Complete 90 Pages Premium Research Report Enabled with 70+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hypothyroidism-market-6958
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
at No comments:

Tuesday, July 21, 2020

Breast Reconstruction & Augmentation Market Dynamics, Comprehensive Analysis, Business Growth Prospects and Opportunities Up To 2023

Breast reconstruction & Augmentation Market Research Report, by Type (Implant reconstruction, Autologous or "Flap" reconstruction), product type (silicone, saline) end user (hospitals & clinics, ambulatory surgical centers) – Global forecast till 2023
Breast Reconstruction & Augmentation Market - Highlights
Globally the rising demand for beauty treatments, anti-aging related cosmetic procedures, and rising demand and development of breast implant products are supporting the growth of the global Breast Reconstruction & Augmentation Market Growth. Growing beauty consciousness and demand to look young are increasing the awareness of breast implants and Breast Reconstruction & Augmentation Market Share procedures in population across the world. There are many large and medium-sized companies involved in developing and manufacturing breast implant products.
According to the International Society of Aesthetic Plastic Surgery, in 2017 report it was mentioned that total breast procedure had been increased by 4% among the population, and in 2016, 3,089,952 number of females undergone breast procedure. The rising expectancy for breast implant products would boost market growth.
Competitive Players:
Some of the key players in the global breast reconstruction & augmentation market are
Allergan Inc, Sientra Inc, GC Aesthetics, Mentor Worldwide LLC (Part of Johnson & Johnson), Establishment Labs, Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG), Groupe Sebbin SAS, HansBiomed Co. Ltd, Laboratoires Arion, Cereplas, Ideal Implant Inc, Shanghai Kangning Medical Supplies Ltd, Guangzhou Wanhe Plastic Materials Co. Ltd and others
Segmentation Analysis:
The Global Breast reconstruction & augmentation market is segmented based on type, product type, end user and region.
On the basis type, the market is segmented into Implant reconstruction, Autologous or "flap" reconstruction. Further, on the basis of product type the market is segmented into silicone, saline. end user is segmented into hospitals & clinics, ambulatory surgical centers, cosmetic surgery centers and others.
Regional Analysis:
The Americas accounts for the largest regional market owing to the increasing number of cosmetic procedures performed annually, a rising number of clinics, and the wide availability of skilled specialists. A number of leading and new players are focusing on research and development to incorporate various new technologies, to overcome issues associated with existing implants. For instance, in September 2016, Allergen received the US FDA approval to market NATRELLE INSPIRA, a cohesive breast implant as its newest category into gummy implants to increase breast fullness.
Europe is anticipated to hold the second largest market for breast implants during the forecast period. According to Statista, the number of silicone type breast augmentation surgeries performed in Italy in 2017 was 48,240.
Moreover, Asia-Pacific is anticipated to exhibit high growth, owing to the reduced cost of implantation procedures, leading to rise of medical tourism in Asian countries such as India, China, and other South-East Asian economies. For instance, according to IndiCure Health Tours Pvt. Ltd, an Indian Medical Tour consulting company, the cost of breast implant surgeries performed in India is almost one-third of the cost for the procedures in the US.
Browse Complete 90 Pages Premium Research Report Enabled with 46Respective Tables and Figures at https://www.marketresearchfuture.com/reports/breast-reconstruction-augmentation-market-7263
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Interventional Neurology Market Size, Share, Trend, Future Growth, Analysis by 2023

The Stakeholders of this Report Include Companies and Intermediaries Engaged in the Manufacture, Commercialization, Providing Services of Interventional Neurology as well as new Entrants Planning to Enter this Market.
Worldwide Key Players
Some of the key players in the global Interventional Neurology Market are Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., B. Braun Melsungen AG, Cook Medical, and others.
Interventional Neurology Market - Highlights
The Global Interventional Neurology Market Size Report is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.
Increasing participation of market players is the key factor driving the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.
Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.
However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.
Segmentation Analysis
The Global Interventional Neurology Devices Industry is segmented based on disease pathology, product, end user and region.
The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.
The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices. The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents. The embolic coils segment includes bare detachable coils and coated detachable coils. The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems. The embolic protection systems segment includes distal filter devices, and balloon occlusion devices. The neurothrombectomy devices are further classified as clot retrieval devices, suction and aspiration devices, and snares. The support devices are further classified as microcatheters, and microguidewires.
Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.
Regional Analysis
The Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.
In 2017, it was estimated that Europe stood second in the global interventional neurology market. This can be attributed to the rising research and development investments.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.
On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region. The growth in this region is attributed to the rising cases neurological conditions. The burden of neurological disorders in African region has been increasing over the years. The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.
Browse Complete 90 Pages Premium Research Report Enabled With 80+ Respective Tables And Figures at https://www.marketresearchfuture.com/reports/interventional-neurology-market-7211
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:

Compression Therapy Market Key Developments Trends, Analysis and Forecasts Till 2023

This MRFR's Market Research Report Offers a Comprehensive and Unbiased analysis of Key Market Dynamics in the Global Compression Therapy Market. The Report Includes an Elaborate Discussion on Historical as well as Current Market Trends, Growth Opportunities and Challenges Backed by Factful Feedbacks.
Compression Therapy Market Highlights:
The Compression Therapy Market Report is expected to grow at an approximate CAGR of 5.2% during forecast period, 2018–2023.                        
Increasing participation of market players is the key factor driving the compression therapy market. For instance, in 2015, SIGVARIS launched diabetic compression socks to provide maximum therapeutic relief for diabetic patients.
Various other factors such as increasing incidence of sports injuries and accidents, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of compression therapy are also expected to propel the growth of the market.
However, low patient compliance for compression garments, adoption of alternative therapies for specific target indications and lack of universally accepted standards for compression products can hinder the market growth over the forecast period.
Segmentation Analysis:
The Global Compression Therapy Products Market is segmented based on technique, product, application and region.
The Global market for compression therapy, by technique is segmented into static compression therapy and dynamic compression therapy.
The market, by product, is segmented into compression garments, compression pumps and compression braces. The compression garments segment is further classified as compression stockings, compression bandages & wraps and others.
Based on application, the market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment and others.
Competitive Players:
Some of the key players in the global compression therapy market are 3M, Medtronic PLC, Bio Compression Systems, Inc., BSN Medical, Medi GmbH & Co. Kg, Paul Hartmann AG, Smith & Nephew PLC., Cardinal Health, Inc., Sigvaris, Sanyleg S.R.L., Tactile Medical, Convatec Inc., DJO Global Inc., Getinge AB, Juzo and others.
Regional Analysis:
The Americas dominated the global market for compression therapy. This can be attributed to the presence of major market players within the region.
Owing to the rising research and development investment and increasing prevalence venous leg ulcers, European compression therapy market stood second in 2017. According to the 2018 study published in the Burns & Trauma journal, venous ulcers are a common chronic problem in many countries especially in Northern Europe. The overall prevalence of this condition is 1%-3% in the population above 65 years of age.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the data suggested by the Australian Institute of Health and Welfare, Australia spent nearly USD 181 billion on health in 2016–2017.
On the other hand, the Middle East and Africa held least share in the global compression therapy market due to the low per capita income, especially within the African region.
Browse Complete Premium 90 Pagers Research Report Enabled with 80+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/compression-therapy-market-7185
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
at No comments:
Subscribe to: Posts (Atom)

Growth Hormone Deficiency Market 2022 Estimation and Forecasts up to 2027

  Growth Hormone Deficiency Market Growth hormone deficiency also called pituitary dwarfism or simply dwarfism, refers to a condition result...